Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sona Nanotech Inc C.SONA

Alternate Symbol(s):  SNANF

Sona Nanotech Inc. is a nanotechnology life sciences company that has developed multiple methods for the manufacturing of various types of gold nanoparticles. The Company is engaged in the research and development of its technology for use in multiplex diagnostic testing platforms and biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of CTAB (cetyltrimethylammonium), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company leverages its core proprietary gold nanorod (GNR) manufacturing technology and laboratory assets to focus on the development of diagnostic tests and biologic reagents, and the advancement of its GNR intellectual property.


CSE:SONA - Post by User

Comment by Pandoraon Jul 03, 2020 4:36pm
180 Views
Post# 31222336

RE:Monday

RE:Monday
wm23four wrote: The US OTC will have a lot of catching up to do MOnday.  Added demand there should push us higher still.  When I first read the PR and saw that although we were validated by MRI, we still had to wait possibly up to another 30 days for addl testing to submit to FDA for EUA/HC for authorization I was thinking it was yet another delay.  Boy, was certainly wrong on that one.  Now realize that although no EUA yet, Its de-risked so buyers are now willing to pay much more, even before EUA.   Very pleasantly surprised with today share price action, just didnt expect a great day like today.  Great set up for Monday.

Have gotten into habit of watching Squak on Street last few months prior to market open.  Jim Cramer is usually on for the 8am to 9am segment (CT)  Often he will talk about covid developments such as drugs, tests, cases, companies in the news, etc  for the upcoming trade day.   He often does this at the beginning of the segment around 8am central time.  If by chance he mentions Sona getting validation by MRIglobal, maybe talks a little about their rapid antigen test etc., it could really set the stage for some Sona fireworks.  Chances of this happening are slim, but you never know?  Can always dream.  




Just as a slight word of caution when dealing with the U.S. OTC market -- have a look at what happened to CYDY (another hot Covid stock) on Tuesday. It had run up on speculation on their therapeutic drug Lerinlomab. On Tuesday a.m. it touched $10 for about an hour and then a notorious shorting outfit by the name of Citron published a statement saying that none of the data being reported by Cytodyn was valid or substantiated. In about 15 - 20 minutes the price plunged from $10 down to $4.65. A couple of hours later Citron removed their statement with a lame duck excuse but by then I assume they made a fortune on their shorts. The share price has recovered a bit to $6.08 but is still a long way from $10.

Citron is known on the Canadian markets as well -- he did the same thing with T.CRH a few years back.

I hate to say I am/was a shareholder in each. CRH never did really recover. I got into CYDY at $2.25 so I am still happy there at $6 as it should also run back up on this Covid scene but those shorters can be unscrupulous.

Not that I'm gunshy but I did take my original investment plus a bit more out of SONA today even though I don't have a big holding. The rest can go for a ride up hopefully.

<< Previous
Bullboard Posts
Next >>